TB Reach

Project Setting

UZT is among recipients of the Stop TB Partnership Wave 9 funding awarded to 11 projects across 8 countries, focusing on innovative approaches to address Drug Resistant TB (DR-TB).

With support from USAID and Global Affairs Canada, the investments support scale-up of newer and shorter all-oral regimens for DR-TB, through the introduction of Xpert MTB/XDR assay for early detection of second-line drug resistance. 

In Zimbabwe, the project has footprint in 19 high burden districts across Bulawayo, Matebeleland South and Midlands provinces, with a buy-in of US$600 000 over the 2-year project life-span.  


  • Project Title: Optimizing SHORRT in Zimbabwe
  • Project Goal: To treat all people with DR-TB
  • Objectives
    1. To provide DST for FQ to at least 90% of patients detected with MDR/RR-TB
    2. To enroll at least 183 (100%) detected DR-TB patients on treatment
    3. To enroll at least 165 (90%) DR-TB patients on an all oral regimen
    4. To ensure a treatment success rate of at least 80% among DR-TB patients initiating treatment

The project will be implemented in Bulawayo, Midlands and Matabeleland South provinces, which contribute two thirds of national case load for DR-TB.

Healthcare Workers Trained
Community Health Workers Sensitised
Community Leaders Sensitised